Vaccine Candidate Against COVID-19 Based on Structurally Modified Plant Virus as an Adjuvant

被引：10
|
作者：
Kovalenko, Angelina O. [1 ]
Ryabchevskaya, Ekaterina M. [1 ]
Evtushenko, Ekaterina A. [1 ]
Manukhova, Tatiana I. [1 ]
Kondakova, Olga A. [1 ]
Ivanov, Peter A. [1 ]
Arkhipenko, Marina V. [1 ]
Gushchin, Vladimir A. [1 ,2 ]
Nikitin, Nikolai A. [1 ]
Karpova, Olga V. [1 ]
机构：
[1] Lomonosov Moscow State Univ, Fac Biol, Dept Virol, Moscow, Russia
[2] Minist Hlth Russian Federat, NF Gamaleya Natl Res Ctr Epidemiol & Microbiol, Moscow, Russia
来源：
FRONTIERS IN MICROBIOLOGY | 2022年 / 13卷
基金：
俄罗斯基础研究基金会;
关键词：
coronaviruses; vaccine candidate; plant virus; adjuvant; tobacco mosaic virus; structurally modified plant virus; RECEPTOR-BINDING DOMAIN; TOBACCO-MOSAIC-VIRUS; SARS-COV-2; SPIKE; SPHERICAL-PARTICLES; SARS-COV; PROTEIN; MUTATIONS; INFECTION; EPITOPES; VIRIONS;
D O I：
10.3389/fmicb.2022.845316
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
A recombinant vaccine candidate has been developed based on the major coronaviruses' antigen (S protein) fragments and a novel adjuvant-spherical particles (SPs) formed during tobacco mosaic virus thermal remodeling. The receptor-binding domain and the highly conserved antigenic fragments of the S2 protein subunit were chosen for the design of recombinant coronavirus antigens. The set of three antigens (Co1, CoF, and PE) was developed and used to create a vaccine candidate composed of antigens and SPs (SPs + 3AG). Recognition of SPs + 3AG compositions by commercially available antibodies against spike proteins of SARS-CoV and SARS-CoV-2 was confirmed. The immunogenicity testing of these compositions in a mouse model showed that SPs improved immune response to the CoF and PE antigens. Total IgG titers against both proteins were 9-16 times higher than those to SPs. Neutralizing activity against SARS-CoV-2 in serum samples collected from hamsters immunized with the SPs + 3AG was demonstrated.
引用
收藏
页数：15
相关论文
共 50 条
  • [41] Vaccine development against tuberculosis before and after Covid-19
    Kaufmann, Stefan H. E.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [42] Potential Protectivity of a Conjugated COVID-19 Vaccine against Tetanus
    Doroud, Delaram
    Ashrafian, Fatemeh
    Javadi, Amir
    Dahmardeh, Sarah
    Banifazl, Mohammad
    Bavand, Anahita
    Sadat Larijani, Mona
    Ramezani, Amitis
    VACCINES, 2024, 12 (03)
  • [43] Peptide-based candidate vaccine against respiratory syncytial virus
    Yusibov, V
    Mett, V
    Mett, V
    Davidson, C
    Musiychuk, K
    Gilliam, S
    Farese, A
    MacVittie, T
    Mann, D
    VACCINE, 2005, 23 (17-18) : 2261 - 2265
  • [44] A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development
    Li, Yingzhu
    Tenchov, Rumiana
    Smoot, Jeffrey
    Liu, Cynthia
    Watkins, Steven
    Zhou, Qiongqiong
    ACS CENTRAL SCIENCE, 2021, 7 (04) : 512 - 533
  • [45] GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults
    Lanini, Simone
    Capone, Stefania
    Antinori, Andrea
    Milleri, Stefano
    Nicastri, Emanuele
    Camerini, Roberto
    Agrati, Chiara
    Castilletti, Concetta
    Mori, Federica
    Sacchi, Alessandra
    Matusali, Giulia
    Gagliardini, Roberta
    Ammendola, Virginia
    Cimini, Eleonora
    Grazioli, Fabiana
    Scorzolini, Laura
    Napolitano, Federico
    Plazzi, Maria M.
    Soriani, Marco
    De Luca, Aldo
    Battella, Simone
    Sommella, Andrea
    Contino, Alessandra M.
    Barra, Federica
    Gentile, Michela
    Raggioli, Angelo
    Shi, Yufang
    Girardi, Enrico
    Maeurer, Markus
    Capobianchi, Maria R.
    Vaia, Francesco
    Piacentini, Mauro
    Kroemer, Guido
    Vitelli, Alessandra
    Colloca, Stefano
    Folgori, Antonella
    Ippolito, Giuseppe
    SCIENCE TRANSLATIONAL MEDICINE, 2022, 14 (627)
  • [46] High throughput and comprehensive approach to develop multiepitope vaccine against minacious COVID-19
    Ojha, Rupal
    Gupta, Nidhi
    Naik, Biswajit
    Singh, Satyendra
    Verma, Vijay Kumar
    Prusty, Dhaneswar
    Prajapati, Vijay Kumar
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 151
  • [47] Immuno-informatics approach for B-cell and T-cell epitope based peptide vaccine design against novel COVID-19 virus
    Singh, Jitender
    Malik, Deepti
    Raina, Ashvinder
    VACCINE, 2021, 39 (07) : 1087 - 1095
  • [48] Quercetin Phytosome® as a potential candidate for managing COVID-19
    Di Pierro, Francesco
    Khan, Amjad
    Bertuccioli, Alexander
    Maffioli, Pamela
    Derosa, Giuseppe
    Khan, Saeed
    Khan, Bilal A.
    Nigar, Roohi
    Ujjan, Ikram
    Devrajani, Bikha R.
    MINERVA GASTROENTEROLOGY, 2021, 67 (02): : 190 - 195
  • [49] Promising Immunotherapies against COVID-19
    Guo, Haodong
    Zhou, Lili
    Ma, Zhenyu
    Tian, Zhixin
    Zhou, Fangfang
    ADVANCED THERAPEUTICS, 2021, 4 (08)
  • [50] Multi-pathogen based chimeric vaccine to fight against COVID-19 and concomitant coinfections
    Rupal Ojha
    Satyendra Singh
    Nidhi Gupta
    Ketan Kumar
    Aditya K. Padhi
    Vijay Kumar Prajapati
    Biotechnology Letters, 2023, 45 : 779 - 797
12345